An audit of clinical service examining the uptake of genetic testing by at-risk family members

Genetics in Medicine

Volumn 14, Issue 1, 2012, Pages 122-128

  Forrest, Laura ^a,b,c   Delatycki, Martin ^a,c,d   Curnow, Lisette ^f   Gen Couns, M ^a   Skene, Loane ^e   Aitken, Maryanne ^a,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d AUSTIN HEALTH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f NONE

Author keywords

at risk family members; clinical audit; family communication; genetic testing; noncancer genetic conditions

Indexed keywords

ARTICLE; CHROMOSOME TRANSLOCATION; FAMILY; FEMALE; FRAGILE X SYNDROME; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENETIC SCREENING; HEALTH SERVICE; HIGH RISK PATIENT; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; RELATIVE; SEX DIFFERENCE; SPINAL MUSCULAR ATROPHY;

CLINICAL AUDIT; COMMUNICATION; FAMILY; FAMILY CHARACTERISTICS; FEMALE; GENETIC COUNSELING; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MALE; RISK; SEX FACTORS; TRANSLOCATION, GENETIC;

EID: 84855533662     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2011.3     Document Type: Article

References (28)

1. Forrest K, Simpson SA, Wilson BJ, et al. To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 2003;64:317-326. (Pubitemid 37236132)
2. Sermijn E, Goelen G, Teugels E, et al. The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation. J Med Genet 2004;41:e23.
3. Andrew SE, Goldberg YP, Kremer B, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 1993;4:398-403. (Pubitemid 23231490)
4. Sobel SK, Cowan DB. Impact of genetic testing for Huntington disease on the family system. Am J Med Genet 2000;90:49-59. (Pubitemid 30010830)
5. Binedell J, Soldan JR, Harper PS. Predictive testing for Huntington's disease: II. Qualitative findings from a study of uptake in South Wales. Clin Genet 1998;54:489-496. (Pubitemid 29002412)
6. Binedell J, Soldan JR, Harper PS. Predictive testing for Huntington's disease: I. Predictors of uptake in South Wales. Clin Genet 1998;54:477-488. (Pubitemid 29002411)
7. Holloway SM, Bernhard B, Campbell H, Lam WW. Uptake of testing for BRCA1/2 mutations in South East Scotland. Eur J Hum Genet 2008;16:906-912.
8. Foster C, Evans DG, Eeles R, et al. Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort. Br J Cancer 2002;86:1209-1216.
9. Hanley JA, Negassa A, Edwardes MD, Forrester JE. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 2003;157:364-375. (Pubitemid 36196757)
10. Goldstein H. Multilevel Statistical Models, 3rd edn. Arnold: London, 2003.
11. McClaren BJ, Metcalfe SA, Aitken M, Massie RJ, Ukoumunne OC, Amor DJ. Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening. Eur J Hum Genet 2010;18:1084-1089.
12. Ormond KE, Mills PL, Lester LA, Ross LF. Effect of family history on disclosure patterns of cystic fibrosis carrier status. Am J Med Genet C Semin Med Genet 2003;119C:70-77. (Pubitemid 37064103)
13. van Rijn MA, de Vries BB, Tibben A, van den Ouweland AM, Halley DJ, Niermeijer MF. DNA testing for fragile X syndrome: implications for parents and family. J Med Genet 1997;34:907-911. (Pubitemid 27480945)
14. Forrest LE, Burke J, Bacic S, Amor DJ. Increased genetic counseling support improves communication of genetic information in families. Genet Med 2008;10:167-172. (Pubitemid 351416812)
15. Suthers GK, Armstrong J, McCormack J, Trott D. Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet 2006;43:665-670. (Pubitemid 44214904)
16. Richards M. Families, kinship and genetics. In: Marteau TM, Richards M (eds). The Troubled Helix: Social and Psychological Implications of the New Human Genetics. Cambridge University Press: Cambridge, 1996:249-273.
17. d'Agincourt-Canning L. Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics 2001;15:231-247. (Pubitemid 32479190)
18. McClaren BJ, Metcalfe SA, Aitken MA, Massie RJ, Ukoumunne OC, Amor DJ. Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening. Eur J Hum Genet 2010;18:1084-1089.
19. Forrest LE, Delatycki MB, Curnow L, Skene L, Aitken M. Genetic health professionals and the communication of genetic information in families: practice during and after a genetic consultation. Am J Med Genet A 2010;152A:1458-1466.
20. Deftos LJ. Genomic torts: the law of the future-the duty of physicians to disclose the presence of a genetic disease to the relatives of their patients with the disease. Univ San Francisco Law Rev 1997;32:105-137.
21. Pate v. Threlkel. Wests South Report: Florida. Supreme Court, 1995:278-282.
22. Safer v. Estate of Pack. Atl Report: New Jersey. Superior Court, Appellate Division, 1996:1188-1193.
23. Papassotiropoulos A. Individualized medicine and pharmacogenomics. Nervenarzt 2007;78:468-469.
24. Wittenberger MD, Hagerman RJ, Sherman SL, et al. The FMR1 premutation and reproduction. Fertil Steril 2007;87:456-465. (Pubitemid 46394554)
25. Cusin V, Clermont O, Gérard B, Chantereau D, Elion J. Prevalence of SMN1 deletion and duplication in carrier and normal populations: implication for genetic counselling. J Med Genet 2003;40:e39.
26. Smith M, Calabro V, Chong B, Gardiner N, Cowie S, du Sart D. Population screening and cascade testing for carriers of SMA. Eur J Hum Genet 2007;15:759-766. (Pubitemid 46965409)
27. Tassicker RJ, Teltscher B, Trembath MK, et al. Problems assessing uptake of Huntington disease predictive testing and a proposed solution. Eur J Hum Genet 2009;17:66-70.
28. Trembath MK, Tassicker RJ, Collins VR, Mansie S, Sheffield LJ, Delatycki MB. Fifteen years of experience in predictive testing for Huntington disease at a single testing center in Victoria, Australia. Genet Med 2006;8:673-680. (Pubitemid 44772794)